Centro di Protonterapia
Hospital
Location:
Trento,
Italy (IT)
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)] (2024)
de Azambuja E, Piccart-Gebhart M, Fielding S, Townend J, Hillman DW, Colleoni M, Roylance R, et al.
Journal article
Update of the ESTRO-EFOMP core curriculum for medical physics experts in radiotherapy (2021)
Garibaldi C, Essers M, Heijmen B, Bertholet J, Koutsouveli E, Schwarz M, Bert C, et al.
Conference contribution